160 related articles for article (PubMed ID: 31494979)
1. Non-melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population-based cohort study.
Yun SJ; Bae JM; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Chung KY
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):746-753. PubMed ID: 31494979
[TBL] [Abstract][Full Text] [Related]
2. Associations of non-melanoma skin cancer and melanoma, extra-cutaneous cancers and smoking in adults: a US population-based study.
Silverberg JI; Ratner D
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1389-97. PubMed ID: 25491569
[TBL] [Abstract][Full Text] [Related]
3. The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea.
Kim HS; Kim HJ; Hong ES; Kim KB; Lee JD; Kang TU; Ahn HS
Br J Dermatol; 2020 Apr; 182(4):907-915. PubMed ID: 31233609
[TBL] [Abstract][Full Text] [Related]
4. Risk of second cancers after the diagnosis of non-melanoma skin cancer in Korean patients.
Roh MR; Shin HJ; Lee SH; Chung KY
J Dermatol; 2012 Jun; 39(6):541-4. PubMed ID: 22380519
[TBL] [Abstract][Full Text] [Related]
5. Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria.
Troyanova P; Danon S; Ivanova T
Neoplasma; 2002; 49(2):81-5. PubMed ID: 12088110
[TBL] [Abstract][Full Text] [Related]
6. Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study.
Bae JM; Chung KY; Yun SJ; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Kim M
J Clin Oncol; 2019 Apr; 37(11):903-911. PubMed ID: 30785828
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
8. Risk of Second Primary Cancer in People with Non-melanoma Skin Cancer: A Nationwide Cohort Study.
Wang SH; Chi CC; Zhao ZH; Tung TH
Cancer Res Treat; 2018 Apr; 50(2):428-435. PubMed ID: 28494532
[TBL] [Abstract][Full Text] [Related]
9. Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
Polverelli N; Elli EM; Abruzzese E; Palumbo GA; Benevolo G; Tiribelli M; Bonifacio M; Tieghi A; Caocci G; D'Adda M; Bergamaschi M; Binotto G; Heidel FH; Cavazzini F; Crugnola M; Pugliese N; Bosi C; Isidori A; Bartoletti D; Auteri G; Latagliata R; Gandolfi L; Martino B; Scaffidi L; Cattaneo D; D'Amore F; Trawinska MM; Stella R; Markovic U; Catani L; Pane F; Cuneo A; Krampera M; Semenzato G; Lemoli RM; Vianelli N; Breccia M; Russo D; Cavo M; Iurlo A; Palandri F
Br J Haematol; 2021 Apr; 193(2):356-368. PubMed ID: 33222197
[TBL] [Abstract][Full Text] [Related]
10. Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea.
Park E; Lee Y; Jue MS
Korean J Intern Med; 2020 Jul; 35(4):917-928. PubMed ID: 31842528
[TBL] [Abstract][Full Text] [Related]
11. Nonmelanoma skin cancer and risk for subsequent malignancy.
Chen J; Ruczinski I; Jorgensen TJ; Yenokyan G; Yao Y; Alani R; Liégeois NJ; Hoffman SC; Hoffman-Bolton J; Strickland PT; Helzlsouer KJ; Alberg AJ
J Natl Cancer Inst; 2008 Sep; 100(17):1215-22. PubMed ID: 18728282
[TBL] [Abstract][Full Text] [Related]
12. Second primary malignancies in patients with non-melanoma skin cancer: Results from a cancer registry-based study in Emilia Romagna, north-east Italy.
Borghi A; Corazza M; Chiaranda G; Michiara M; Mangone L; Caruso B; Falcini F; Maestri I; Ferretti S
Cancer Epidemiol; 2019 Aug; 61():176-184. PubMed ID: 31301588
[TBL] [Abstract][Full Text] [Related]
13. Risk of skin cancer in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan.
Tseng HW; Shiue YL; Tsai KW; Huang WC; Tang PL; Lam HC
Medicine (Baltimore); 2016 Jun; 95(26):e4070. PubMed ID: 27368048
[TBL] [Abstract][Full Text] [Related]
14. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
Long MD; Martin CF; Pipkin CA; Herfarth HH; Sandler RS; Kappelman MD
Gastroenterology; 2012 Aug; 143(2):390-399.e1. PubMed ID: 22584081
[TBL] [Abstract][Full Text] [Related]
15. Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study.
Song F; Qureshi AA; Giovannucci EL; Fuchs CS; Chen WY; Stampfer MJ; Han J
PLoS Med; 2013; 10(4):e1001433. PubMed ID: 23630459
[TBL] [Abstract][Full Text] [Related]
16. Skin cancer risk of menopausal hormone therapy in a Korean cohort.
Yuk JS; Lee SK; Uh JA; Seo YS; Kim M; Kim MS
Sci Rep; 2023 Jun; 13(1):10572. PubMed ID: 37386069
[TBL] [Abstract][Full Text] [Related]
17. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
[TBL] [Abstract][Full Text] [Related]
18. Non-melanoma skin cancer and risk of Alzheimer's disease and all-cause dementia.
Schmidt SA; Ording AG; Horváth-Puhó E; Sørensen HT; Henderson VW
PLoS One; 2017; 12(2):e0171527. PubMed ID: 28225789
[TBL] [Abstract][Full Text] [Related]
19. The Risk of Internal Malignancy Following a Prior Diagnosis of Non-Melanoma Skin Cancer in Solid Organ Transplant Recipients.
Gal N; Didkovsky E; Hodak E; Davidovici BB
Isr Med Assoc J; 2022 Apr; 24(4):219-224. PubMed ID: 35415979
[TBL] [Abstract][Full Text] [Related]
20. Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009.
Jung GW; Dover DC; Salopek TG
Br J Dermatol; 2014 Jan; 170(1):136-43. PubMed ID: 24443913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]